Article

<strong>Repurposing of Chloroquine and Its Derivative, Hydroxychloroquine for COVID-19: Implications for People Living with HIV in Africa</strong>

2020-04-22

Abstract excerpt

The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2, has been declared by the World Health Organization (WHO) as a pandemic. Unfortunately, finding a vaccine or developing drugs from the scratch is a time-consuming luxury given the widespread and high fatality rates of the virus. In the short term, repurposing of drugs already in use seem to be the most rational s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 397d7d9a-5996-57c3-82f6-31824ce28236
DOI: 10.20944/preprints202004.0395.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

<strong>Repurposing of Chloroquine and Its Derivative, Hydroxychloroquine for COVID-19: Implications for People Living with HIV in Africa</strong>DOI 10.20944/preprints202004.0395.v1Read

HYDROXYCHLOROQUINE FOR THE TREATMENT OF SEVERE RESPIRATORY INFECTION BY COVID-19: A RANDOMIZED CONTROLLED TRIALSemantic proximity Read

Hydroxychloroquine/Chloroquine in COVID-19 With Focus on Hospitalized Patients – A Systematic ReviewSemantic proximity Read

Hydroxychloroquine and mortality risk of patients with COVID-19: a systematic review and meta-analysis of human comparative studiesSemantic proximity Read

COVID-19 and the Generation of Novel Scientific Knowledge in a Dangerous Time.Semantic proximity Read

Mass Intake of Hydroxychloroquine or Chloroquine in the Present Context of the COVID-19 Outbreak: Possible Consequences in Endemic Malaria SettingsSemantic proximity Read

Hydroxychloroquine Alone or in Combination with Cobicistat-Boosted Darunavir for Treatment of Mild COVID-19: A Cluster-Randomized Clinical TrialSemantic proximity Read

Unlike Chloroquine, mefloquine inhibits SARS-CoV-2 infection in physiologically relevant cells and does not induce viral variantsSemantic proximity Read

Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trialSemantic proximity Read

Pooled evidence precision of clinical trials on hydroxychloroquine for Covid-19 treatment was stabilized eight months after the outbreakSemantic proximity Read

The haze around pharmacokinetics of hydroxychloroquineSemantic proximity Read

Chloroquine and artemisinin: six decades of research--what next?Semantic proximity Read

Preventing disease after exposure to COVID-19 using hydroxychloroquine: A summary of a protocol for exploratory re-analysis of age and time-nuanced effectsSemantic proximity Read